MFN2 and acute myeloid leukemia: Moreover, we incubated control or MFN2 OE AML cells with the prototypic mTORC1 inhibitor rapamycin [37], and observed that rapamycin decreased the G1/G0 ratio, and prevented the increased proportion of G1-phase cells induced by MFN2 OE (Supplementary Fig. S4K).